Navigation Links
Genome analysis of brain tumors showing the way to new treatment strategies
Date:7/26/2012

mors. At the German Cancer Research Center (DKFZ), researchers collaborating with Bayer Healthcare are currently working to develop an agent which specifically inhibits the growth of cells with more than two sets of chromosomes.

About one third of individual mutations in medulloblastoma are found in genes that play a part in what are called epigenetic modifications. "This finding shows once more that drugs influencing such modifications will become increasingly important in cancer treatment," says Professor Dr. Stefan Pfister, a pediatrician and molecular biologist. DKFZ and Heidelberg University Hospital are already testing such promising substances to treat specific pediatric tumors.

The total number of genomic alterations in medulloblastoma increases with the age of patients. "Although many scientists have supposed that there is such a correlation, it has never been documented before," Stefan Pfister explains. "We suspect, however, that the foundation for medulloblastoma is laid already during embryonic development."

For the first time, the PedBrain researchers have also found what are called fusion genes in medulloblastoma. Such genes are formed when, due to genetic accidents, cancer-promoting genes are fused together and new proteins occur as a result. Such fusion genes cause a number of cancers such as chronic myelogenous leukemia (CML). For this cancer, researchers have succeeded in developing a very effective drug against the BCR-ABL fusion gene, which is highly specific for leukemia cells.

"Along with a multitude of individually occurring mutations, we were able to define a number of typical groups of mutations, which will show us the way to new strategies of fighting medulloblastoma", says Peter Lichter to sum up. "Given the genetic complexity and heterogeneity of this tumor type, a useful future approach would be to analyze the tumor genome in each affected child in order to identify the most promising treatment." '/>"/>

Contact: Dr. Sibylle Kohlstdt
s.kohlstaedt@dkfz.de
Helmholtz Association of German Research Centres
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Mayo Clinic launches whole genome breast cancer study
2. 2 genetic deletions in human genome linked to the development of aggressive prostate cancer
3. Control of gene expression: Histone occupancy in your genome
4. Scientists Map Melanomas Genome
5. Genomes show how Staph bacteria gain resistance to last-line drug
6. Scientists Map the Tomatos Genome
7. Entire Genome of Human Fetus Deciphered
8. Bonobo Genome Sheds Light on Their Links to Chimps, Humans
9. Bioinformatics experts at the CNIO explore additional coding potential hidden in the human genome
10. Genome-wide analysis shows previously undetected abnormalities in parents of affected children
11. New Stanford method enables sequencing of fetal genomes using only maternal blood sample
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... ... 2015 , ... Displays and Exhibits , a top online retailer of ... all purchases that include branding. Enter price code brand2015 for a ten percent discount ... packaging and promotional materials, all should integrate the company logo to communicate the brand. ...
(Date:6/29/2015)... Wethersfield, CT (PRWEB) , ... June 29, 2015 ... ... their centers recognized by the independent auditor of customer service for the 40-center ... of more than 1,100 skilled nursing centers in the United States in one ...
(Date:6/29/2015)... ... June 29, 2015 , ... Assurex Health, a precision medicine ... and chronic pain conditions, has announced appointments to three key leadership roles, according ... Senior Vice President, Chief Financial Officer; Craig S. Lewis, Senior Vice President, Chief ...
(Date:6/29/2015)... ... June 29, 2015 , ... New ... that fewer than 10 percent of U.S. state and local governments have implemented ... an implementation deadline for NG9-1-1. , “Mobile phones have surpassed land lines ...
(Date:6/29/2015)... ... 29, 2015 , ... Blue Cross and Blue Shield of ... Markets division, which includes the company’s commercial health plan portfolio of products and ... and international reach. Mary Ellen Anderson now holds the title of vice president, ...
Breaking Medicine News(10 mins):Health News:Stock Up on Logo Branding Tools Reduced this Month and Next Month from Displays and Exhibits 2Health News:National HealthCare Centers Receive 'Customer Experience Awards' 2Health News:National HealthCare Centers Receive 'Customer Experience Awards' 3Health News:National HealthCare Centers Receive 'Customer Experience Awards' 4Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 2Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 3Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 2Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 3Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 4Health News:Blue Cross and Blue Shield of Minnesota announces two new leadership appointments within its Commercial Markets division 2Health News:Blue Cross and Blue Shield of Minnesota announces two new leadership appointments within its Commercial Markets division 3
... http://healthworldnet.com ) receives three Standard of Excellence awards,from ... of,outstanding web sites., The awards were given ... Excellence, and Portal Standard of Excellence. "We are ... CEO of Health,WorldNet, Inc. "The site has only ...
... Medical,Technologies, Inc. (Nasdaq: PMTI ), a leading ... today announced financial,results for the third quarter ended ... 30, 2008 were $24.2 million, of which $19.2 ... $1.0 million,were funded development revenues, and $1.25 million ...
... Mid-Atlantic Region, ATLANTA, Oct. 30 AmeriCare ( ... the opening of its,latest franchises serving Howard, Montgomery, and ... states in the union, Maryland is in the,top 20 ... Marylanders is over the,age of 60. AmeriCare of Maryland ...
... The American Fertility Association,introduces Manicures and Martinis, a ... together in a casual setting over manicures and,martinis ... fertility. It,s,free, relaxing, fun, and educational. The series ... by leading professionals in the reproductive medical,field, including ...
... China Sky One,Medical, Inc. ("China Sky One Medical" ... fully integrated pharmaceutical company producing over-the-counter,drugs in the ... it,recently obtained production approval from the State Food ... its newly developed drugs., Sodium ferulate by ...
... N.J., Oct. 30 Orchid Cellmark Inc.,(Nasdaq: ORCH ), ... its financial results for the third quarter of,2008., Total ... to $15.6 million for the third quarter of 2007. The ... to a year ago was,largely due to lower revenues in ...
Cached Medicine News:Health News:HealthWorldNet.com Receives Three Excellence Awards 2Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 2Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 3Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 4Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 5Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 6Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 7Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 8Health News:Palomar Medical Reports Financial Results for Third Quarter 2008 9Health News:Caregiving Company AmeriCare Adds Franchise in Maryland 2Health News:The American Fertility Association Announces Plan to Help Young Women Preserve Fertility 2Health News:China Sky One Medical, Inc. Obtains Production Approval for Two New Drugs 2Health News:Orchid Cellmark Reports Third Quarter 2008 Financial Results 2Health News:Orchid Cellmark Reports Third Quarter 2008 Financial Results 3Health News:Orchid Cellmark Reports Third Quarter 2008 Financial Results 4Health News:Orchid Cellmark Reports Third Quarter 2008 Financial Results 5Health News:Orchid Cellmark Reports Third Quarter 2008 Financial Results 6Health News:Orchid Cellmark Reports Third Quarter 2008 Financial Results 7Health News:Orchid Cellmark Reports Third Quarter 2008 Financial Results 8
(Date:6/29/2015)... SAN FRANCISCO , June 29, ... company,s novel blood-draw technology has received CE Mark ... quality from the European Union. This regulatory milestone ... alternative to one of the most common procedures ... Velano Vascular,s proprietary device reduces the ...
(Date:6/29/2015)... , June 29, 2015 ... and predicted revenues ,Where is the market for dermatological ... market? Visiongain ,s new report shows you potential ... and prospects. Our 310 page report ... most lucrative areas in the industry and the future ...
(Date:6/29/2015)... Calif. , June 29, 2015  The ... innovative features to cars on the basis of ... The industry is now on the verge of ... cars. While automotive HWW non-critical features such as ... be present in 30 to 40 percent of ...
Breaking Medicine Technology:Velano Vascular Receives CE Mark For Novel Blood Draw Technology Designed to Reduce Needle Exposures for Hospitalized Patients and Healthcare Providers 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 3Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 4Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 5Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 6Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 7Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 8Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 2Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 3Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 4
... Expected in November 2008, BOTHELL, Wash., Oct. 9 ... the completion of patient enrollment and dosing,for the third ... and,efficacy of its formulation of 12-hour extended-release (ER) ibuprofen ... top-line,results from this pivotal trial in November 2008. Ibuprofen ...
... Will Reduce Animal Use in Cosmetics and Chemicals ... Corp. today announced,that results of a recently completed ... EpiDerm in vitro human skin tissue,equivalent. The test ... to be accepted as a validated alternative to ...
Cached Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2
... A concentrated enzymatic cleanser ... semi-automated hematology instruments. It ... all Abbott CELL-DYN® hematology ... instruments. The shelf life ...
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Streck-Diluent III Plus is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 3000, 3500 and 3700. The shelf...
Streck-Diluent IIIA is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1700. The shelf life is one year f...
Medicine Products: